Laddar...
HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
The development of direct-acting antivirals (DAAs) has revolutionized the state-of-the art treatment of HCV infections, with sustained virologic response rates above 90%. However, viral variants harboring substitutions referred to as resistance-associated substitutions (RASs) may be present in basel...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2020-06-01
|
| Serie: | Frontiers in Cellular and Infection Microbiology |
| Ämnen: | |
| Länkar: | https://www.frontiersin.org/article/10.3389/fcimb.2020.00325/full |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|